000 01690 a2200481 4500
005 20250517050959.0
264 0 _c20160915
008 201609s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep13519
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNishio, Naomi
245 0 0 _aGADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance.
_h[electronic resource]
260 _bScientific reports
_cAug 2015
300 _a13519 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdipogenesis
_xdrug effects
650 0 4 _aAging
_xpathology
650 0 4 _aAnimals
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aCHO Cells
650 0 4 _aCarcinoma, Hepatocellular
_xcomplications
650 0 4 _aCricetinae
650 0 4 _aCricetulus
650 0 4 _aDiet, High-Fat
650 0 4 _aFatty Liver
_xcomplications
650 0 4 _aInsulin
_xmetabolism
650 0 4 _aInsulin Resistance
650 0 4 _aJNK Mitogen-Activated Protein Kinases
_xmetabolism
650 0 4 _aLiver
_xdrug effects
650 0 4 _aLiver Neoplasms
_xcomplications
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNon-alcoholic Fatty Liver Disease
_xcomplications
650 0 4 _aObesity
_xcomplications
650 0 4 _aPalmitic Acid
_xpharmacology
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProtein Phosphatase 1
_xdeficiency
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aIsobe, Ken-ichi
773 0 _tScientific reports
_gvol. 5
_gp. 13519
856 4 0 _uhttps://doi.org/10.1038/srep13519
_zAvailable from publisher's website
999 _c25210639
_d25210639